New ADHD drug on PBS
Lisdexamfetamine dimesilate has been listed on the PBS as a once-daily treatment for attention deficit hyperactivity disorder (ADHD).
The PBS indication is for patients aged six to 18 years diagnosed with ADHD who need continuous coverage for over 12 hours.
It can be taken as a whole capsule or mixed in water. The drug should be initiated at 30mg once daily in the morning before slowly adjusted.